Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 57412
Gene Symbol: AS3MT
AS3MT
0.300 Biomarker group CTD_human Relation of polymorphism of arsenic metabolism genes to arsenic methylation capacity and developmental delay in preschool children in Taiwan. 28235556 2017
Entrez Id: 171023
Gene Symbol: ASXL1
ASXL1
0.020 GeneticVariation group BEFREE MLL2, EP300, CREBBP, ASXL1) are also mutated in human developmental disorders thus pointing towards a remarkable and unexpected convergence between somatic and germline genetics. 22287508 2012
Entrez Id: 171023
Gene Symbol: ASXL1
ASXL1
0.020 GeneticVariation group BEFREE Here, we investigated molecular mechanisms pertaining to NC-related symptoms in Bohring-Opitz syndrome (BOS), a developmental disorder linked to mutations in the Polycomb group factor Additional sex combs-like 1 (ASXL1). 31006630 2019
Entrez Id: 478
Gene Symbol: ATP1A3
ATP1A3
0.010 GeneticVariation group BEFREE We here report a pediatric case of catastrophic early life epilepsy, respiratory failure, postnatal microcephaly, and severe developmental disability associated with a novel heterozygous ATP1A3 mutation. 30392841 2019
Entrez Id: 488
Gene Symbol: ATP2A2
ATP2A2
0.010 Biomarker group BEFREE Mutations in human ATP2A2, ATP2C1 genes, encoding housekeeping isoforms of the endoplasmic reticulum (SERCA2) and secretory pathway (SPCA1) pumps, respectively, confer autosomal dominant disorders of the skin, whereas mutations in other isoforms underlie various muscular, neurological, or developmental disorders. 26608610 2016
Entrez Id: 27032
Gene Symbol: ATP2C1
ATP2C1
0.010 Biomarker group BEFREE Mutations in human ATP2A2, ATP2C1 genes, encoding housekeeping isoforms of the endoplasmic reticulum (SERCA2) and secretory pathway (SPCA1) pumps, respectively, confer autosomal dominant disorders of the skin, whereas mutations in other isoforms underlie various muscular, neurological, or developmental disorders. 26608610 2016
Entrez Id: 546
Gene Symbol: ATRX
ATRX
0.020 Biomarker group BEFREE ATRX was identified over 20 years ago as the gene responsible for a rare developmental disorder characterized by α-thalassemia and intellectual disability. 26646632 2015
Entrez Id: 546
Gene Symbol: ATRX
ATRX
0.020 GeneticVariation group BEFREE We place emphasis on the chromatin remodeler ATRX, which is mutated in the developmental disorder for which it is named, α-thalassemia, mental retardation, X-linked syndrome, and at high frequency in a number of adult and pediatric tumors. 28062559 2017
Entrez Id: 551
Gene Symbol: AVP
AVP
0.010 Biomarker group BEFREE Alcohol dehydrogenase (ADH) is important for preventing alcohol toxicity and developmental disorders, and may be involved in other diseases including neurodegenerative diseases. 30936015 2019
Entrez Id: 9577
Gene Symbol: BABAM2
BABAM2
0.010 Biomarker group BEFREE The characteristic age-dependent focal sharp wave (fsw) found on the EEG in this disorder segregates as an autosomal dominant trait in families with probands with BRE and acts as a neurobiological marker for the increased risk of developing BRE, other benign partial epilepsies of childhood, and other developmental disorders in these families. 8232778 1993
Entrez Id: 583
Gene Symbol: BBS2
BBS2
0.020 GeneticVariation group BEFREE Here, we report the identification of a founder mutation in the BBS2 gene as the cause for the increased incidence of this developmental disorder in the Hutterite population. 20618352 2010
Entrez Id: 583
Gene Symbol: BBS2
BBS2
0.020 Biomarker group BEFREE Bardet-Biedl syndrome (BBS: OMIM 209900) is a rare developmental disorder that exhibits significant clinical and genetic heterogeneity. 14976158 2004
Entrez Id: 604
Gene Symbol: BCL6
BCL6
0.010 Biomarker group BEFREE Consequently, dysfunction of vertebrate POZ-ZF proteins, such as promyelocytic leukemia zinc finger (PLZF), B cell lymphoma 6 (Bcl-6), hypermethylated in cancer 1 (HIC-1), Kaiso, ZBTB7 and Fanconi anemia zinc finger (FAZF), has been linked directly or indirectly to tumorigenesis and developmental disorders. 16996269 2006
Entrez Id: 627
Gene Symbol: BDNF
BDNF
0.010 Biomarker group BEFREE Increased BDNF production and changes in the metabolism of tryptophan are associated with many ASD characteristics, showing particularly strong associations with childhood autism and Intellectual and Developmental Disabilities. 30033880 2018
Entrez Id: 168667
Gene Symbol: BMPER
BMPER
0.010 AlteredExpression group BEFREE In this study, we achieved continuous knockdown of B. mori Period (BmPer) gene expression in the B. mori ovary cell line (BmN), and generated a Per-KD B. mori model with developmental disorders including small individual cells and slow growth. 28393918 2017
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.010 GeneticVariation group BEFREE Cardiofaciocutaneous syndrome (CFCS) is a rare developmental disorder that is phenotypically similar to Noonan syndrome and is associated with mutations in BRAF, MEK1, MEK2, and KRAS. 31125963 2019
Entrez Id: 680
Gene Symbol: BRS3
BRS3
0.010 Biomarker group BEFREE In this Review, we highlight central mechanisms by which primary cilia coordinate HH, G protein-coupled receptor, WNT, receptor tyrosine kinase and transforming growth factor-β (TGFβ)/bone morphogenetic protein (BMP) signalling and illustrate how defects in the balanced output of ciliary signalling events are coupled to developmental disorders and disease progression. 30733609 2019
Entrez Id: 777
Gene Symbol: CACNA1E
CACNA1E
0.010 GeneticVariation group BEFREE We establish pathogenic variants in CACNA1E as a cause of DEEs and suggest facilitated R-type calcium currents as a disease mechanism for human epilepsy and developmental disorders. 30343943 2018
Entrez Id: 93664
Gene Symbol: CADPS2
CADPS2
0.010 Biomarker group BEFREE Therefore, CAPS2(-/-) mice will be a useful model animal in which to study aspects of the neuropathology and behaviors characteristic of developmental disorders. 19238500 2009
Entrez Id: 79823
Gene Symbol: CAMKMT
CAMKMT
0.300 Biomarker group CTD_human Calmodulin Methyltransferase Is Required for Growth, Muscle Strength, Somatosensory Development and Brain Function. 26247364 2015
Entrez Id: 842
Gene Symbol: CASP9
CASP9
0.010 Biomarker group BEFREE Failing to activate caspase-9 has profound physiological and pathophysiological outcomes, leading to degenerative and developmental disorders even cancer. 28177918 2017
Entrez Id: 867
Gene Symbol: CBL
CBL
0.300 Biomarker group CTD_human We describe a dominant developmental disorder resulting from germline missense CBL mutations, which is characterized by impaired growth, developmental delay, cryptorchidism and a predisposition to juvenile myelomonocytic leukemia (JMML). 20694012 2010
Entrez Id: 998
Gene Symbol: CDC42
CDC42
0.030 Biomarker group BEFREE Deregulation of Cdc42 has been associated with several human diseases and developmental disorders. 30714195 2019
Entrez Id: 998
Gene Symbol: CDC42
CDC42
0.030 GeneticVariation group BEFREE This condition, along with the developmental disorders associated with RAC1 and CDC42 missense mutations, highlight the importance of RHO GTPase members and effectors in neuronal development. 30290153 2018
Entrez Id: 998
Gene Symbol: CDC42
CDC42
0.030 GeneticVariation group BEFREE Here, we report that missense variants in CDC42, a gene encoding a small GTPase functioning as an intracellular signaling node, underlie a clinically heterogeneous group of phenotypes characterized by variable growth dysregulation, facial dysmorphism, and neurodevelopmental, immunological, and hematological anomalies, including a phenotype resembling Noonan syndrome, a developmental disorder caused by dysregulated RAS signaling. 29394990 2018